When pathogenic bacteria meet the intestinal microbiota

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 371, Issue 1707, 2016, Pages

  Rolhion, Nathalie ^a,b,c   Chassaing, Benoit ^d  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c INRA   (France)

^d GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Inflammation; Intestinal microbiota; Nutrient; Pathogenic bacteria; Virulence

Indexed keywords

ABSORPTION; BACTERIUM; DIGESTIVE SYSTEM; IMMUNE SYSTEM; MATURATION; NUTRIENT; PATHOGEN; VIRULENCE;

BACTERIA (MICROORGANISMS);

ANIMAL; BACTERIAL PHENOMENA AND FUNCTIONS; GASTROINTESTINAL TRACT; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE FLORA; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; BACTERIAL PHYSIOLOGICAL PHENOMENA; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; HUMANS;

EID: 84988851408     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2015.0504     Document Type: Review

References (110)

1. Round JL, Mazmanian SK. 2009 The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313-323. (doi:10.1038/nri2515)
2. Flint HJ, Scott KP, Louis P, Duncan SH. 2012 The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 9, 577-589. (doi:10.1038/nrgastro.2012.156)
3. McKenney PT, Pamer EG. 2015 From hype to hope: the gut microbiota in enteric infectious disease. Cell 163, 1326-1332. (doi:10.1016/j.cell.2015.11.032)
4. Kamada N, Chen GY, Inohara N, Nunez G. 2013 Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 14, 685-690. (doi:10.1038/ni.2608)
5. Chow J, Tang H, Mazmanian SK. 2011 Pathobionts of the gastrointestinal microbiota and inflammatory disease. Curr. Opin. Immunol. 23, 473-480. (doi:10.1016/j.coi.2011.07.010)
6. Ducluzeau R, Railbaud P. 1989 Bacterial interactions within the digestive tract. Rev. Sci. Tech. Off. Int. Epiz. 8, 313-332. (doi:10.20506/rst.8.2.410)
7. Theriot CM, Young VB. 2015 Interactions between the gastrointestinal microbiome and Clostridium difficile. Annu. Rev. Microbiol. 69, 445-461. (doi:10.1146/annurev-micro-091014-104115)
8. Osawa N, Mitsuhashi S. 1964 Infection of germeree mice with Shigella Flexneri 3a. Jpn. J. Exp. Med. 34, 77-80.
9. Fukuda S, Toh H, Taylor TD, Ohno H, Hattori M. 2012 Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microbes 3, 449-454. (doi:10.4161/gmic.21214)
10. Fukuda S et al. 2011 Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543-547. (doi:10.1038/nature09646)
11. Bohnhoff M, Drake BL, Miller CP. 1954 Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc. Soc. Exp. Biol. Med. 86, 132-137. (doi:10.3181/00379727-86-21030)
12. Lawley TD et al. 2009 Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect. Immun. 77, 3661-3669. (doi:10.1128/IAI.00558-09)
13. Buffie CG, Pamer EG. 2013 Microbiota-mediated colonization resistance against intestinal pathogens. Nat. Rev. Immunol. 13, 790-801. (doi:10.1038/nri3535)
14. Kamada N, Kim YG, Sham HP, Vallance BA, Puente JL, Martens EC, Nunez G. 2012 Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336, 1325-1329. (doi:10.1126/science.1222195)
15. Gantois I, Ducatelle R, Pasmans F, Haesebrouck F, Hautefort I, Thompson A, Hinton JC, Van Immerseel F. 2006 Butyrate specifically down-regulates Salmonella pathogenicity island 1 gene expression. Appl. Environ. Microbiol. 72, 946-949. (doi:10.1128/AEM.72.1.946-949.2006)
16. Shin R, Suzuki M, Morishita Y. 2002 Influence of intestinal anaerobes and organic acids on the growth of enterohaemorrhagic Escherichia coli O157:H7. J. Med. Microbiol. 51, 201-206. (doi:10.1099/0022-1317-51-3-201)
17. Kommineni S et al. 2015 Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. Nature 526, 719-722. (doi:10.1038/nature15524)
18. Rea MC, Sit CS, Clayton E, O’Connor PM, Whittal RM, Zheng J, Vederas JC, Ross RP, Hill C. 2010 Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc. Natl Acad. Sci. USA 107, 9352-9357. (doi:10.1073/pnas.0913554107)
19. Schamberger GP, Diez-Gonzalez F. 2002 Selection of recently isolated colicinogenic Escherichia coli strains inhibitory to Escherichia coli O157:H7. J. Food Prot. 65, 1381-1387.
20. Pinto AL, Fernandes M, Pinto C, Albano H, Castilho F, Teixeira P, Gibbs PA. 2009 Characterization of anti-Listeria bacteriocins isolated from shellfish: potential antimicrobials to control non-fermented seafood. Int. J. Food Microbiol. 129, 50-58. (doi:10.1016/j.ijfoodmicro.2008.11.005)
21. Chanos P, Williams DR. 2011 Anti-Listeria bacteriocin-producing bacteria from raw ewe’s milk in northern Greece. J. Appl. Microbiol. 110, 757-768. (doi:10.1111/j.1365-2672.2010.04932.x)
22. Donia MS, Cimermancic P, Schulze CJ, Wieland Brown LC, Martin J, Mitreva M, Clardy J, Linington RG, Fischbach MA. 2014 A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell 158, 1402-1414. (doi:10.1016/j.cell.2014.08.032)
23. Walsh CJ, Guinane CM, Hill C, Ross RP, O’Toole PW, Cotter PD. 2015 In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project’s reference genome database. BMC Microbiol. 15, 183. (doi:10.1186/s12866-015-0515-4)
24. Human Microbiome Project C. 2012 Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214. (doi:10.1038/nature11234)
25. Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT. 2015 Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519, 92-96. (doi:10.1038/nature14232)
26. Theriot CM, Bowman AA, Young VB. 2016 Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine. mSphere 1, e00045-15. (doi:10.1128/mSphere.00045-15)
27. Britton RA, Young VB. 2014 Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 146, 1547-1553. (doi:10.1053/j.gastro.2014.01.059)
28. Sorg JA, Sonenshein AL. 2010 Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J. Bacteriol. 192, 4983-4990. (doi:10.1128/JB.00610-10)
29. Buffie CG et al. 2015 Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517, 205-208. (doi:10.1038/nature13828)
30. Weingarden AR, Chen C, Bobr A, Yao D, Lu Y, Nelson VM, Sadowsky MJ, Khoruts A. 2014 Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G310-G319. (doi:10.1152/ajpgi.00282.2013)
31. Karlsson J, Putsep K, Chu H, Kays RJ, Bevins CL, Andersson M. 2008 Regional variations in Paneth cell antimicrobial peptide expression along the mouse intestinal tract. BMC Immunol. 9, 37. (doi:10.1186/1471-2172-9-37)
32. Rios D, Wood MB, Li J, Chassaing B, Gewirtz AT, Williams IR. 2015 Antigen sampling by intestinal M cells is the principal pathway initiating mucosal IgA production to commensal enteric bacteria. Mucosal Immunol. 9, 907-916. (doi:10.1038/mi.2015.121)
33. Bevins CL, Salzman NH. 2011 Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat. Rev. Microbiol. 9, 356-368. (doi:10.1038/nrmicro2546)
34. Cash HL, Whitham CV, Behrendt CL, Hooper LV. 2006 Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313, 1126-1130. (doi:10.1126/science.1127119)
35. Fransen F et al. 2015 BALB/c and C57BL/6 mice differ in polyreactive IgA abundance, which impacts the generation of antigen-specific IgA and microbiota diversity. Immunity 43, 527-540. (doi:10.1016/j.immuni.2015.08.011)
36. Dolle L, Tran HQ, Etienne-Mesmin L, Chassaing B. 2016 Policing of gut microbiota by the adaptive immune system. BMC Med. 14, 27. (doi:10.1186/s12916-016-0573-y)
37. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. 2005 An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118. (doi:10.1016/j.cell.2005.05.007)
38. Ivanov II, Frutos RD, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR. 2008 Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337-349. (doi:10.1016/j.chom.2008.09.009)
39. Ivanov II et al. 2009 Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498. (doi:10.1016/j.cell.2009.09.033)
40. Gaboriau-Routhiau V et al. 2009 The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689. (doi:10.1016/j.immuni.2009.08.020)
41. Lecuyer E et al. 2014 Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues to induce gut IgA and specific T helper 17 cell responses. Immunity 40, 608-620. (doi:10.1016/j.immuni.2014.03.009)
42. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. 2004 Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241. (doi:10.1016/j.cell.2004.07.002)
43. Araki A et al. 2005 MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 40, 16-23. (doi:10.1007/s00535-004-1492-9)
44. Zhang B et al. 2014 Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18. Science 346, 861-865. (doi:10.1126/science.1256999)
45. Atarashi K et al. 2013 Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236. (doi:10.1038/nature12331)
46. Arpaia N et al. 2013 Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451-455. (doi:10.1038/nature12726)
47. Kim CH, Park J, Kim M. 2014 Gut microbiota-derived short-chain fatty acids, T cells, and inflammation. Immune Network 14, 277-288. (doi:10.4110/in.2014.14.6.277)
48. Furusawa Y et al. 2013 Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446-450. (doi:10.1038/nature12721)
49. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, Glickman JN, Garrett WS. 2013 The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573. (doi:10.1126/science.1241165)
50. Bates JM, Akerlund J, Mittge E, Guillemin K. 2007 Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2, 371-382. (doi:10.1016/j.chom.2007.10.010)
51. Beumer C, Wulferink M, Raaben W, Fiechter D, Brands R, Seinen W. 2003 Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS-mediated diseases, attenuates LPS toxicity in mice and piglets. J. Pharmacol. Exp. Ther. 307, 737-744. (doi:10.1124/jpet.103.056606)
52. Koyama I, Matsunaga T, Harada T, Hokari S, Komoda T. 2002 Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin. Biochem. 35, 455-461. (doi:10.1016/S0009-9120(0200330-2)
53. Chassaing B, Gewirtz AT. 2016 Has provoking microbiota aggression driven the obesity epidemic? Bioessays 38, 122-128. (doi:10.1002/bies.201500116)
54. Wlodarska M, Willing B, Keeney KM, Menendez A, Bergstrom KS, Gill N, Russell SL, Vallance BA, Finlay BB. 2011 Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 79, 1536-1545. (doi:10.1128/IAI.01104-10)
55. Willemsen LE, Koetsier MA, van Deventer SJ, van Tol EA. 2003 Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1 and E(2 production by intestinal myofibroblasts. Gut 52, 1442-1447. (doi:10.1136/gut.52.10.1442)
56. Shimotoyodome A, Meguro S, Hase T, Tokimitsu I, Sakata T. 2000 Short chain fatty acids but not lactate or succinate stimulate mucus release in the rat colon. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 125, 525-531. (doi:10.1016/S1095-6433(0000183-5)
57. Cameron EA, Sperandio V. 2015 Frenemies: signaling and nutritional integration in pathogenmicrobiota-host interactions. Cell Host Microbe 18, 275-284. (doi:10.1016/j.chom.2015.08.007)
58. Ng KM et al. 2013 Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502, 96-99. (doi:10.1038/nature12503)
59. Ferreyra JA, Wu KJ, Hryckowian AJ, Bouley DM, Weimer BC, Sonnenburg JL. 2014 Gut microbiotaproduced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. Cell Host Microbe 16, 770-777. (doi:10.1016/j.chom.2014.11.003)
60. Curtis MM, Hu Z, Klimko C, Narayanan S, Deberardinis R, Sperandio V. 2014 The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe 16, 759-769. (doi:10.1016/j.chom.2014.11.005)
61. Pham NT, Lawley TD. 2014 Pathogens’ exploitation of the intestinal food web. Cell Host Microbe 16, 703-705. (doi:10.1016/j.chom.2014.11.012)
62. Pacheco AR, Curtis MM, Ritchie JM, Munera D, Waldor MK, Moreira CG, Sperandio V. 2012 Fucose sensing regulates bacterial intestinal colonization. Nature 492, 113-117. (doi:10.1038/nature11623)
63. Giel JL, Sorg JA, Sonenshein AL, Zhu J. 2010 Metabolism of bile salts in mice influences spore germination in Clostridium difficile. PLoS ONE 5, e8740. (doi:10.1371/journal.pone.0008740)
64. Maier L, Barthel M, Stecher B, Maier RJ, Gunn JS, Hardt WD. 2014 Salmonella Typhimurium strain ATCC14028 requires H2-hydrogenases for growth in the gut, but not at systemic sites. PLoS ONE 9, e110187. (doi:10.1371/journal.pone.0110187)
65. Bertin Y, Girardeau JP, Chaucheyras-Durand F, Lyan B, Pujos-Guillot E, Harel J, Martin C. 2011 Enterohaemorrhagic Escherichia coli gains a competitive advantage by using ethanolamine as a nitrogen source in the bovine intestinal content. Environ. Microbiol. 13, 365-377. (doi:10.1111/j.1462-2920.2010.02334.x)
66. Kendall MM, Gruber CC, Parker CT, Sperandio V. 2012 Ethanolamine controls expression of genes encoding components involved in interkingdom signaling and virulence in enterohemorrhagic Escherichia coli O157:H7. mBio 3, e00050-12. (doi:10.1128/mBio.00050-12)
67. Thiennimitr P et al. 2011 Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc. Natl Acad. Sci. USA 108, 17480-17485. (doi:10.1073/pnas.1107857108)
68. Joseph B, Przybilla K, Stuhler C, Schauer K, Slaghuis J, Fuchs TM, Goebel W. 2006 Identification of Listeria monocytogenes genes contributing to intracellular replication by expression profiling and mutant screening. J. Bacteriol. 188, 556-568. (doi:10.1128/JB.188.2.556-568.2006)
69. Everard A et al. 2013 Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066-9071. (doi:10.1073/pnas.1219451110)
70. Schneeberger M, Everard A, Gomez-Valades AG, Matamoros S, Ramirez S, Delzenne NM, Gomis R, Claret M, Cani PD. 2015 Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci. Rep. 5, 16643. (doi:10.1038/srep16643)
71. Ganesh BP, Klopfleisch R, Loh G, Blaut M. 2013 Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimuriuminfected gnotobiotic mice. PLoS ONE 8, e74963. (doi:10.1371/journal.pone.0074963)
72. Carvalho FA et al. 2012 Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 12, 139-152. (doi:10.1016/j.chom.2012.07.004)
73. Chassaing B, Koren O, Carvalho FA, Ley RE, Gewirtz AT. 2014 AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut 63, 1069-1080. (doi:10.1136/gutjnl-2013-304909)
74. Vayssier-Taussat M et al. 2014 Shifting the paradigm from pathogens to pathobiome: new concepts in the light of meta-omics. Front. Cell Infect. Microbiol. 4, 29. (doi:10.3389/fcimb.2014.00029)
75. Kamdar K et al. 2016 Genetic and metabolic signals during acute enteric bacterial infection alter the microbiota and drive progression to chronic inflammatory disease. Cell Host Microbe 19, 21-31. (doi:10.1016/j.chom.2015.12.006)
76. Garsin DA. 2010 Ethanolamine utilization in bacterial pathogens: roles and regulation. Nat. Rev. Microbiol. 8, 290-295. (doi:10.1038/nrmicro2334)
77. Korbel JO, Doerks T, Jensen LJ, Perez-Iratxeta C, Kaczanowski S, Hooper SD, Andrade MA, Bork P. 2005 Systematic association of genes to phenotypes by genome and literature mining. PLoS Biol. 3, e134. (doi:10.1371/journal.pbio.0030134)
78. Fabich AJ et al. 2008 Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine. Infect. Immun. 76, 1143-1152. (doi:10.1128/IAI.01386-07)
79. Le Bouguenec C, Schouler C. 2011 Sugar metabolism, an additional virulence factor in enterobacteria. Int. J. Med. Microbiol. 301, 1-6. (doi:10.1016/j.ijmm.2010.04.021)
80. Saha R, Saha N, Donofrio RS, Bestervelt LL. 2013 Microbial siderophores: a mini review. J. Basic Microbiol. 53, 303-317. (doi:10.1002/jobm.201100552)
81. Fischbach MA, Lin H, Liu DR, Walsh CT. 2006 How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat. Chem. Biol. 2, 132-138. (doi:10.1038/nchembio771)
82. Singh V, Yeoh BS, Xiao X, Kumar M, Bachman M, Borregaard N, Joe B, Vijay-Kumar M. 2015 Interplay between enterobactin, myeloperoxidase and lipocalin 2 regulates E. coli survival in the inflamed gut. Nat. Commun. 6, 7113. (doi:10.1038/ncomms8113)
83. Rivera-Chavez F et al. 2013 Salmonella uses energy taxis to benefit from intestinal inflammation. PLoS Pathog. 9, e1003267. (doi:10.1371/journal.ppat.1003267)
84. Winter SE et al. 2010 Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467, 426-429. (doi:10.1038/nature09415)
85. Winter SE et al. 2013 Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339, 708-711. (doi:10.1126/science.1232467)
86. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. 2007 Hostmediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 204. (doi:10.1016/j.chom.2007.08.002)
87. Darfeuille-Michaud A et al. 2004 High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology 127, 412-421. (doi:10.1053/j.gastro.2004.04.061)
88. Chassaing B, Darfeuille-Michaud A. 2011 The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1720-1728. (doi:10.1053/j.gastro.2011.01.054)
89. Nash JH et al. 2010 Genome sequence of adherentinvasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics 11, 667. (doi:10.1186/1471-2164-11-667)
90. Miquel S et al. 2010 Complete genome sequence of Crohn’s disease-associated adherent-invasive E. coli strain LF82. PLoS ONE 5, e12714. (doi:10.1371/journal.pone.0012714)
91. Wu L et al. 2005 Recognition of host immune activation by Pseudomonas aeruginosa. Science 309, 774-777. (doi:10.1126/science.1112422)
92. Unterweger D, Miyata ST, Bachmann V, Brooks TM, Mullins T, Kostiuk B, Provenzano D, Pukatzki S. 2014 The Vibrio cholerae type VI secretion system employs diverse effector modules for intraspecific competition. Nat. Commun. 5, 3549. (doi:10.1038/ncomms4549)
93. MacIntyre DL, Miyata ST, Kitaoka M, Pukatzki S. 2010 The Vibrio cholerae type VI secretion system displays antimicrobial properties. Proc. Natl Acad. Sci. USA 107, 19520-19524. (doi:10.1073/pnas.1012931107)
94. Patankar CV, Joshi LM. 1985 Bacteriocin production in Salmonella. J. Postgrad. Med. 31, 46-51.
95. Sousa MA, Mendes EN, Apolonio AC, Farias Lde M, Magalhaes PP. 2010 Bacteriocin production by Shigella sonnei isolated from faeces of children with acute diarrhoea. APMIS 118, 125-135. (doi:10.1111/j.1600-0463.2009.02570.x)
96. Horak V. 1994 Seventy colicin types of Shigella sonnei and an indicator system for their determination. Zentralbl. Bakteriol. 281, 24-29. (doi:10.1016/S0934-8840(1180633-X)
97. Kaewklom S, Samosornsuk S, Pipatsatitpong D, Aunpad R. 2013 Colicin type 7 produced by majority of Shigella sonnei isolated from Thai patients with diarrhoea. Braz. J. Microbiol. 44, 731-736. (doi:10.1590/S1517-83822013000300010)
98. Smajs D, Pilsl H, Braun V. 1997 Colicin U, a novel colicin produced by Shigella boydii. J. Bacteriol. 179, 4919-4928.
99. Padilla C, Lobos O, Brevis P, Abaca P, Hubert E. 2006 Plasmid-mediated bacteriocin production by Shigella flexneri isolated from dysenteric diarrhoea and their transformation into Escherichia coli. Lett. Appl. Microbiol. 42, 300-303. (doi:10.1111/j.1472-765X.2005.01829.x)
100. Belizario JE, Napolitano M. 2015 Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front. Microbiol. 6, 1050. (doi:10.3389/fmicb.2015.01050)
101. van Nood E et al. 2013 Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407-415. (doi:10.1056/NEJMoa1205037)
102. Cotter PD, Ross RP, Hill C. 2013 Bacteriocins—a viable alternative to antibiotics? Nat. Rev. Microbiol. 11, 95-105. (doi:10.1038/nrmicro2937)
103. Rea MC et al. 2011 Effect of broad-and narrowspectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc. Natl Acad. Sci. USA 108(Suppl. 1, 4639-4644. (doi:10.1073/pnas.1001224107)
104. Corr SC, Li Y, Riedel CU, O’Toole PW, Hill C, Gahan CG. 2007 Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl Acad. Sci. USA 104, 7617-7621. (doi:10.1073/pnas.0700440104)
105. Koskella B, Meaden S. 2013 Understanding bacteriophage specificity in natural microbial communities. Viruses 5, 806-823. (doi:10.3390/v5030806)
106. Sulakvelidze A, Alavidze Z, Morris Jr JG. 2001 Bacteriophage therapy. Antimicrob. Agents Chemother. 45, 649-659. (doi:10.1128/AAC.45.3.649-659.2001)
107. Abedon ST. 2014 Phage therapy: eco-physiological pharmacology. Scientifica 2014, 581639. (doi:10.1155/2014/581639)
108. Tsui J, Jacobs J, Braun J. 2014 Bacteriophages as a therapeutic strategy to target adherent, invasive Escherichia coli associated with inflammatory bowel disease. SACNAS National Conference, 16-18 October, Los Angeles, CA.
109. Schauder S, Bassler BL. 2001 The languages of bacteria. Genes Dev. 15, 1468-1480. (doi:10.1101/gad.899601)
110. Rutherford ST, Bassler BL. 2012 Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb. Perspect. Med. 2, a012427. (doi:10.1101/cshperspect.a012427)